Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease

International Journal of Cardiology

Volumn 118, Issue 3, 2007, Pages 345-349

  Fernández Miranda, Consuelo ^a   Yebra, Miguel ^a   Aranda, Jose Luis ^a   Gómez, Pilar ^a   Martínez, Joaquín ^a   Núñez, Victor ^a   Gómez de la Cámara, Agustín ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Carotid intima media thickness; Coronary disease; Folic acid treatment; Homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; STATIN;

AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID INTIMA MEDIA THICKENING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG EFFECT; FEMALE; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; MUTATION; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; CAROTID ARTERY DISEASES; CAROTID STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY, DOPPLER;

EID: 34247594392     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.031     Document Type: Article

References (33)

1. Urbina E., Sathanur R., Srinivasan R., et al. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa heart study). Am J Cardiol 90 (2002) 953-958
2. Chambless L., Folsom A.R., Davis V., et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 155 (2002) 38-47
3. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., and Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
4. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson S.J. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
5. O'Leary D.H., and Polak J.F. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90 (2002) 18L-21L (suppl)
6. Bots M.L., and Grobee D.E. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther 16 (2002) 341-351
7. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
8. Homocysteine Studies Collaboration. Homocysteine and risk of ischaemic heart disease and stroke. A meta-analysis. JAMA 288 (2002) 2015-2022
9. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
10. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., and Schouten E.G. MTHFR 677C → T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (2002) 2023-2031
11. Tsai M.Y., Arnett D.K., Eckfeldt J.H., Williams R.R., and Ellison R.C. Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis 151 (2000) 519-524
12. Kawamoto R., Doi T., and Tokunaga H. Association of plasma homocysteine concentrations with carotid atherosclerosis in elderly Japanese. Intern Med 40 (2001) 1189-1194
13. Passaro A., Vanini A., Calzoni F., et al. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157 (2001) 175-180
14. Ravera M., Viazzi F., Berruti V., et al. 5-10 methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. Am J Hypertens 14 (2001) 371-376
15. Durga J., Verhoef P., Bots M.L., and Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 176 (2004) 1-19
16. Pancharuniti N., Lewis C.A., Sauberlich H.E., et al. Plasma homocyst(e)ine, folate and vitamin B12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59 (1994) 940-948
17. Robinson K., Arheart K., Refsum H., et al. Low circulating folate and vitamin B6 concentrations. Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97 (1998) 437-443
18. Durga J., Bots M.L., Schouten E.G., Kok F.J., and Verhoef P. Low concentrations of folate, not hyperhomocysteinemia, are associated with carotid intima-media thickness. Atherosclerosis 179 (2005) 285-292
19. Bazzano L.A., He J., Ogden L.G., et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study: National Health and Nutrition Examination Survey. Stroke 33 (2002) 1183-1188
20. He K., Merchant A., Rimm E.B., et al. Folate, vitamin B6 and B12 intakes in relation to risk of stroke among men. Stroke 35 (2004) 169-174
21. Voutilainen S., Rissanen T.H., Virtanen J., Lakka T.A., and Salonen J.T. Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 103 (2001) 2674-2680
22. Marcucci R., Zanazzi M., Bertoni E., et al. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients. Transplantation 75 (2003) 1551-1555
23. Till U., Jentsch A., Röhl P., et al. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamin B6 and B12. Atherosclerosis 181 (2005) 131-135
24. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine level and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
25. Roe D.A. Nutritional assessment of the elderly. World Rev Nutr Diet 48 (1986) 85-113
26. Gonzalez-Gross M. Una vitamina en constante evolución. Med Clin (Barc) 119 (2002) 627-635
27. Hackam D.G., Peterson J.C., and Spence D. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine level above and below 14 μmol/L. Am J Hypertens 13 (2000) 105-110
28. Kawamoto R., Kohara K., Tabara Y., et al. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis. J Hum Genet 46 (2001) 506-510
29. Corti R., Fuster V., Fayad Z.A., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions. Two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
30. Wiklund O., Hulthe J., Wikstrand J., Schmidt C., Olofsson S.-O., and Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia. A 3-year randomized study. Stroke 33 (2002) 572-577
31. Lonn E.M., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 (2001) 919-925
32. Zanchetti A., Bond M.G., Hennig M., et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double blind, long term trial. Circulation 106 (2002) 2422-2427
33. Crouse J.R., Tang R., Espeland M.A., et al. Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation 106 (2002) 2061-2066